Mesenchymal stromal cells as multifunctional cellular therapeutics – a potential role for extracellular vesicles

Transfusion and Apheresis Science

Volumn 55, Issue 1, 2016, Pages 62-69

  Stephen, Jillian ^a   Bravo, Elena Lopez ^a   Colligan, David ^a   Fraser, Alasdair R ^a   Petrik, Juraj ^a   Campbell, John D M ^a  

^a SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

Cellular therapy; Extracellular vesicles; Immune modulation; Mesenchymal stromal cells; T cells

Indexed keywords

CELL FUNCTION; CELL PROLIFERATION; CELL THERAPY; EXOSOME; HUMAN; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STROMA CELL; NONHUMAN; REVIEW; T LYMPHOCYTE; BIOLOGICAL THERAPY; BLOOD; IMMUNOLOGY; MEMBRANE MICROPARTICLE; METABOLISM; PROCEDURES;

CYTOKINE;

CELL- AND TISSUE-BASED THERAPY; CELL-DERIVED MICROPARTICLES; CYTOKINES; IMMUNOMODULATION; MESENCHYMAL STROMAL CELLS;

EID: 84983490299     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2016.07.011     Document Type: Review

References (68)

1. [1] Squillaro, T., Peluso, G., Galderisi, U., Clinical trials with mesenchymal stem cells: an update. Cell Transplant 25:5 (2016), 829–848 Epub 2015/10/02.
2. [2] Wu, H., Wen, D., Mahato, R.I., Third-party mesenchymal stem cells improved human islet transplantation in a humanized diabetic mouse model. Mol Ther 21:9 (2013), 1778–1786 Epub 2013/06/15.
3. [3] Keating, A., Mesenchymal stromal cells: new directions. Cell Stem Cell 10:6 (2012), 709–716 Epub 2012/06/19.
4. [4] Bianco, P., Cao, X., Frenette, P.S., Mao, J.J., Robey, P.G., Simmons, P.J., et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med 19:1 (2013), 35–42 Epub 2013/01/09.
5. [5] de Mare-Bredemeijer, E.L., Mancham, S., Verstegen, M.M., de Ruiter, P.E., van Gent, R., O'Neill, D., et al. Human graft-derived mesenchymal stromal cells potently suppress alloreactive T-cell responses. Stem Cells Dev 24:12 (2015), 1436–1447 Epub 2015/03/07.
6. [6] Shimabukuro-Vornhagen, A., Draube, A., Liebig, T.M., Rothe, A., Kochanek, M., von Bergwelt-Baildon, M.S., The immunosuppressive factors IL-10, TGF-beta, and VEGF do not affect the antigen-presenting function of CD40-activated B cells. J Exp Clin Cancer Res, 31, 2012, 47 Epub 2012/05/18.
7. [7] Francois, M., Copland, I.B., Yuan, S., Romieu-Mourez, R., Waller, E.K., Galipeau, J., Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-gamma licensing. Cytotherapy 14:2 (2012), 147–152 Epub 2011/10/28.
8. [8] Hoogduijn, M.J., Roemeling-van Rhijn, M., Engela, A.U., Korevaar, S.S., Mensah, F.K., Franquesa, M., et al. Mesenchymal stem cells induce an inflammatory response after intravenous infusion. Stem Cells Dev 22:21 (2013), 2825–2835 Epub 2013/06/19.
9. [9] Laitinen, A., Oja, S., Kilpinen, L., Kaartinen, T., Moller, J., Laitinen, S., et al. A robust and reproducible animal serum-free culture method for clinical-grade bone marrow-derived mesenchymal stromal cells. Cytotechnology, 2015, 10.1007/s10616-014-9841-x Epub 2015/03/18.
10. [10] Cruz, F.F., Borg, Z.D., Goodwin, M., Sokocevic, D., Wagner, D., McKenna, D.H., et al. Freshly thawed and continuously cultured human bone marrow-derived mesenchymal stromal cells comparably ameliorate allergic airways inflammation in immunocompetent mice. Stem Cells Transl Med 4:6 (2015), 615–624 Epub 2015/05/01.
11. [11] Fekete, N., Rojewski, M.T., Furst, D., Kreja, L., Ignatius, A., Dausend, J., et al. GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC. PLoS ONE, 7(8), 2012, e43255 Epub 2012/08/21.
12. [12] Timmers, L., Lim, S.K., Arslan, F., Armstrong, J.S., Hoefer, I.E., Doevendans, P.A., et al. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res 1:2 (2007), 129–137 Epub 2007/11/01.
13. [13] Asami, T., Ishii, M., Fujii, H., Namkoong, H., Tasaka, S., Matsushita, K., et al. Modulation of murine macrophage TLR7/8-mediated cytokine expression by mesenchymal stem cell-conditioned medium. Mediators Inflamm, 2013, 2013, 264260 Epub 2013/11/06.
14. [14] Bartunek, J., Vanderheyden, M., Vandekerckhove, B., Mansour, S., De Bruyne, B., De Bondt, P., et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation, 112(9 Suppl.), 2005 I178–83; Epub 2005/09/15.
15. [15] Estrada, R., Li, N., Sarojini, H., An, J., Lee, M.J., Wang, E., Secretome from mesenchymal stem cells induces angiogenesis via Cyr61. J Cell Physiol 219:3 (2009), 563–571 Epub 2009/01/27.
16. [16] Lavoie, J.R., Rosu-Myles, M., Uncovering the secrets of mesenchymal stem cells. Biochimie 95:12 (2013), 2212–2221 Epub 2013/07/03.
17. [17] Harding, C., Heuser, J., Stahl, P., Endocytosis and intracellular processing of transferrin and colloidal gold-transferrin in rat reticulocytes: demonstration of a pathway for receptor shedding. Eur J Cell Biol 35:2 (1984), 256–263 Epub 1984/11/01.
18. [18] Heijnen, H.F., Schiel, A.E., Fijnheer, R., Geuze, H.J., Sixma, J.J., Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94:11 (1999), 3791–3799 Epub 1999/11/26.
19. [19] Peters, P.J., Geuze, H.J., Van der Donk, H.A., Slot, J.W., Griffith, J.M., Stam, N.J., et al. Molecules relevant for T cell-target cell interaction are present in cytolytic granules of human T lymphocytes. Eur J Immunol 19:8 (1989), 1469–1475 Epub 1989/08/01.
20. [20] Blanchard, N., Lankar, D., Faure, F., Regnault, A., Dumont, C., Raposo, G., et al. TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J Immunol 168:7 (2002), 3235–3241 Epub 2002/03/22.
21. [21] Raposo, G., Nijman, H.W., Stoorvogel, W., Liejendekker, R., Harding, C.V., Melief, C.J., et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183:3 (1996), 1161–1172 Epub 1996/03/01.
22. [22] Chen, T.S., Lai, R.C., Lee, M.M., Choo, A.B., Lee, C.N., Lim, S.K., Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res 38:1 (2010), 215–224 Epub 2009/10/24.
23. [23] Zhang, B., Yin, Y., Lai, R.C., Tan, S.S., Choo, A.B., Lim, S.K., Mesenchymal stem cells secrete immunologically active exosomes. Stem Cells Dev 23:11 (2014), 1233–1244 Epub 2013/12/26.
24. [24] Yanez-Mo, M., Siljander, P.R., Andreu, Z., Zavec, A.B., Borras, F.E., Buzas, E.I., et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles, 4, 2015, 27066 Epub 2015/05/17.
25. [25] Thery, C., Amigorena, S., Raposo, G., Clayton, A., Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol, Chapter 3(Unit 3 22), 2006, 10.1002/0471143030.cb0322s30 Epub 2008/01/30.
26. [26] Thery, C., Boussac, M., Veron, P., Ricciardi-Castagnoli, P., Raposo, G., Garin, J., et al. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 166:12 (2001), 7309–7318 Epub 2001/06/08.
27. [27] Gould, S.J., Raposo, G., As we wait: coping with an imperfect nomenclature for extracellular vesicles. J Extracell Vesicles, 2, 2013 Epub 2013/09/07.
28. [28] Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319:5867 (2008), 1244–1247 Epub 2008/03/01.
29. [29] Baietti, M.F., Zhang, Z., Mortier, E., Melchior, A., Degeest, G., Geeraerts, A., et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 14:7 (2012), 677–685 Epub 2012/06/05.
30. [30] Escola, J.M., Kleijmeer, M.J., Stoorvogel, W., Griffith, J.M., Yoshie, O., Geuze, H.J., Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem 273:32 (1998), 20121–20127 Epub 1998/08/01.
31. [31] Rani, S., Ryan, A.E., Griffin, M.D., Ritter, T., Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications. Mol Ther 23:5 (2015), 812–823 Epub 2015/04/15.
32. [32] Cocucci, E., Racchetti, G., Meldolesi, J., Shedding microvesicles: artefacts no more. Trends Cell Biol 19:2 (2009), 43–51 Epub 2009/01/16.
33. [33] Ratajczak, J., Wysoczynski, M., Hayek, F., Janowska-Wieczorek, A., Ratajczak, M.Z., Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20:9 (2006), 1487–1495 Epub 2006/06/23.
34. [34] Mulcahy, L.A., Pink, R.C., Carter, D.R., Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles, 3, 2014 Epub 2014/08/22.
35. [35] Feng, D., Zhao, W.L., Ye, Y.Y., Bai, X.C., Liu, R.Q., Chang, L.F., et al. Cellular internalization of exosomes occurs through phagocytosis. Traffic 11:5 (2010), 675–687 Epub 2010/02/09.
36. [36] Parolini, I., Federici, C., Raggi, C., Lugini, L., Palleschi, S., De Milito, A., et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem 284:49 (2009), 34211–34222 Epub 2009/10/06.
37. [37] Robbins, P.D., Morelli, A.E., Regulation of immune responses by extracellular vesicles. Nat Rev Immunol 14:3 (2014), 195–208 Epub 2014/02/26.
38. [38] Ludwig, A.K., Giebel, B., Exosomes: small vesicles participating in intercellular communication. Int J Biochem Cell Biol 44:1 (2012), 11–15 Epub 2011/10/26.
39. [39] Bian, S., Zhang, L., Duan, L., Wang, X., Min, Y., Yu, H., Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Mol Med 92:4 (2014), 387–397 Epub 2013/12/18.
40. [40] He, J., Wang, Y., Sun, S., Yu, M., Wang, C., Pei, X., et al. Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model. Nephrology (Carlton) 17:5 (2012), 493–500 Epub 2012/03/01.
41. [41] Mokarizadeh, A., Delirezh, N., Morshedi, A., Mosayebi, G., Farshid, A.A., Mardani, K., Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling. Immunol Lett 147:1–2 (2012), 47–54 Epub 2012/06/19.
42. [42] Budoni, M., Fierabracci, A., Luciano, R., Petrini, S., Di Ciommo, V., Muraca, M., The immunosuppressive effect of mesenchymal stromal cells on B lymphocytes is mediated by membrane vesicles. Cell Transplant 22:2 (2013), 369–379 Epub 2013/02/26.
43. [43] Favaro, E., Carpanetto, A., Lamorte, S., Fusco, A., Caorsi, C., Deregibus, M.C., et al. Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes. Diabetologia 57:8 (2014), 1664–1673 Epub 2014/05/20.
44. [44] Blazquez, R., Sanchez-Margallo, F.M., de la Rosa, O., Dalemans, W., Alvarez, V., Tarazona, R., et al. Immunomodulatory potential of human adipose mesenchymal stem cells derived exosomes on in vitro stimulated T cells. Front Immunol, 5, 2014, 556 Epub 2014/11/22.
45. [45] Del Fattore, A., Luciano, R., Pascucci, L., Goffredo, B.M., Giorda, E., Scapaticci, M., et al. Immunoregulatory effects of mesenchymal stem cell-derived extracellular vesicles on T lymphocytes. Cell Transplant 24:12 (2015), 2615–2627 Epub 2015/02/20.
46. [46] Phinney, D.G., Di Giuseppe, M., Njah, J., Sala, E., Shiva, S., St Croix, C.M., et al. Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun, 6, 2015, 8472 Epub 2015/10/08.
47. [47] Favaro, E., Carpanetto, A., Caorsi, C., Giovarelli, M., Angelini, C., Cavallo-Perin, P., et al. Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients. Diabetologia 59:2 (2015), 325–333 Epub 2015/11/26.
48. [48] Conforti, A., Scarsella, M., Starc, N., Giorda, E., Biagini, S., Proia, A., et al. Microvesicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro. Stem Cells Dev 23:21 (2014), 2591–2599 Epub 2014/06/18.
49. [49] Gouveia de Andrade, A.V., Bertolino, G., Riewaldt, J., Bieback, K., Karbanova, J., Odendahl, M., et al. Extracellular vesicles secreted by bone marrow- and adipose tissue-derived mesenchymal stromal cells fail to suppress lymphocyte proliferation. Stem Cells Dev 24:11 (2015), 1374–1376 Epub 2015/03/18.
50. [50] Lotvall, J., Hill, A.F., Hochberg, F., Buzas, E.I., Di Vizio, D., Gardiner, C., et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles, 3, 2014, 26913 Epub 2014/12/30.
51. [51] Del Fattore, A., Luciano, R., Saracino, R., Battafarano, G., Rizzo, C., Pascucci, L., et al. Differential effects of extracellular vesicles secreted by mesenchymal stem cells from different sources on glioblastoma cells. Expert Opin Biol Ther 15:4 (2015), 495–504 Epub 2014/12/30.
52. [52] Akyurekli, C., Le, Y., Richardson, R.B., Fergusson, D., Tay, J., Allan, D.S., A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles. Stem Cell Rev 11:1 (2015), 150–160 Epub 2014/08/06.
53. [53] Lai, R.C., Arslan, F., Lee, M.M., Sze, N.S., Choo, A., Chen, T.S., et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4:3 (2010), 214–222 Epub 2010/02/09.
54. [54] Arslan, F., Lai, R.C., Smeets, M.B., Akeroyd, L., Choo, A., Aguor, E.N., et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res 10:3 (2013), 301–312 Epub 2013/02/13.
55. [55] Feng, Y., Huang, W., Wani, M., Yu, X., Ashraf, M., Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS ONE, 9(2), 2014, e88685 Epub 2014/02/22.
56. [56] Hu, G.W., Li, Q., Niu, X., Hu, B., Liu, J., Zhou, S.M., et al. Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice. Stem Cell Res Ther, 6, 2015, 10 Epub 2015/08/14.
57. [57] Xin, H., Li, Y., Cui, Y., Yang, J.J., Zhang, Z.G., Chopp, M., Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab 33:11 (2013), 1711–1715 Epub 2013/08/22.
58. [58] Chen, J., Li, Y., Wang, L., Zhang, Z., Lu, D., Lu, M., et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32:4 (2001), 1005–1011 Epub 2001/04/03.
59. [59] Xin, H., Li, Y., Buller, B., Katakowski, M., Zhang, Y., Wang, X., et al. Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells 30:7 (2012), 1556–1564 Epub 2012/05/19.
60. [60] Doeppner, T.R., Herz, J., Gorgens, A., Schlechter, J., Ludwig, A.K., Radtke, S., et al. Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med 4:10 (2015), 1131–1143 Epub 2015/09/05.
61. [61] Bruno, S., Grange, C., Deregibus, M.C., Calogero, R.A., Saviozzi, S., Collino, F., et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20:5 (2009), 1053–1067 Epub 2009/04/25.
62. [62] Gatti, S., Bruno, S., Deregibus, M.C., Sordi, A., Cantaluppi, V., Tetta, C., et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant 26:5 (2011), 1474–1483 Epub 2011/02/18.
63. [63] Zhu, Y.G., Feng, X.M., Abbott, J., Fang, X.H., Hao, Q., Monsel, A., et al. Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells 32:1 (2014), 116–125 Epub 2013/08/14.
64. [64] Tan, C.Y., Lai, R.C., Wong, W., Dan, Y.Y., Lim, S.K., Ho, H.K., Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell Res Ther, 5(3), 2014, 76 Epub 2014/06/12.
65. [65] Kordelas, L., Rebmann, V., Ludwig, A.K., Radtke, S., Ruesing, J., Doeppner, T.R., et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia 28:4 (2014), 970–973 Epub 2014/01/22.
66. [66] Chen, T.S., Arslan, F., Yin, Y., Tan, S.S., Lai, R.C., Choo, A.B., et al. Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. J Transl Med, 9, 2011, 47 Epub 2011/04/26.
67. [67] Clayton, A., Mitchell, J.P., Court, J., Linnane, S., Mason, M.D., Tabi, Z., Human tumor-derived exosomes down-modulate NKG2D expression. J Immunol 180:11 (2008), 7249–7258 Epub 2008/05/21.
68. [68] Lamparski, H.G., Metha-Damani, A., Yao, J.Y., Patel, S., Hsu, D.H., Ruegg, C., et al. Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods 270:2 (2002), 211–226 Epub 2002/10/16.